Baseline characteristics of study patients
| . | Study group (n = 40) . | Elective stenting (n = 20) . |
|---|---|---|
| Gender (M/F) | 29/11 | 15/5 |
| Age, y (range) | 61.8 (36-87) | 63.7 (31-79) |
| Active smokers, n (%) | 23 (56) | 10 (50) |
| Hypercholesterolemia, n (%) | 30 (75) | 15 (75) |
| Systemic hypertension, n (%) | 33 (83) | 14 (70) |
| Diabetes mellitus, n (%) | 10 (25) | 5 (25) |
| Prior myocardial infarction, n (%) | 4 (10) | 10 (50) |
| Prior PTCA, n (%) | 3 (8) | 1 (5) |
| Single-vessel disease, n (%) | 18 (45) | 5 (25) |
| Double-vessel disease, n (%) | 14 (35) | 8 (40) |
| Triple-vessel disease, n (%) | 8 (20) | 6 (30) |
| Target vessel, n (%) | ||
| LAD | 16 (40) | 8 (40) |
| LCx | 17 (43) | 7 (35) |
| RCA | 7 (18) | 5 (30) |
| Peak CK, U/L (range) | 1325 (230-5962) | < 80 |
| . | Study group (n = 40) . | Elective stenting (n = 20) . |
|---|---|---|
| Gender (M/F) | 29/11 | 15/5 |
| Age, y (range) | 61.8 (36-87) | 63.7 (31-79) |
| Active smokers, n (%) | 23 (56) | 10 (50) |
| Hypercholesterolemia, n (%) | 30 (75) | 15 (75) |
| Systemic hypertension, n (%) | 33 (83) | 14 (70) |
| Diabetes mellitus, n (%) | 10 (25) | 5 (25) |
| Prior myocardial infarction, n (%) | 4 (10) | 10 (50) |
| Prior PTCA, n (%) | 3 (8) | 1 (5) |
| Single-vessel disease, n (%) | 18 (45) | 5 (25) |
| Double-vessel disease, n (%) | 14 (35) | 8 (40) |
| Triple-vessel disease, n (%) | 8 (20) | 6 (30) |
| Target vessel, n (%) | ||
| LAD | 16 (40) | 8 (40) |
| LCx | 17 (43) | 7 (35) |
| RCA | 7 (18) | 5 (30) |
| Peak CK, U/L (range) | 1325 (230-5962) | < 80 |
Except for peak CK, none of the differences between the two groups were statistically significant.
PTCA indicates percutaneous transluminal coronary angioplasty; CK, creatine kinase; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; RCA, right coronary artery.